When your immune system is locked in a perpetual battle and your structural tissues are compromised, your body rapidly burns through its foundational nutritional reserves, leaving you depleted at a cellular level
It is the race to control the global oral obesity drug market, oral GLP-1 adoption, triple agonist development, and the next generation of incretin therapies that could define a $150 billion metabolic health opportunity
GIP is similar to GLP-1
The FDA-designated label for cyanocobalamin states that it can be given either intramuscularly or subcutaneously
Decreased appetite while therapeutically desirable, this can occasionally lead to inadequate nutritional intake if not monitored
The pathogenesis originates from an imbalance in hepatic lipid homeostasis, where excessive triglyceride accumulation results from increased lipid influx, enhanced de novo lipogenesis, and impaired lipid export or oxidation